IRF1 and prostate cancer: The overexpression of DTX3L and BAL1 promotes the phosphorylation of STAT1 and represses the transcription of IFN regulatory factor-1 (IRF-1), thus enhancing the proliferation, metastasis, and chemoresistance of prostate cancer cells (Bachmann et al., 2014).